Jeffrey L. Ives's Net Worth

$837 Thousand

Estimate Recalculated Nov 7, 2024 05:14PM EST

Who is Jeffrey L. Ives

Jeffrey L. Ives does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Cara Therapeutics, Inc., and Acumen Pharmaceuticals, Inc..

SEC CIK

Jeffrey L. Ives's CIK is 0001614096

Past Insider Trading and Trends

2020 was Jeffrey L. Ives's most active year for acquiring shares with 9 total transactions. Jeffrey L. Ives's most active month to acquire stocks was the month of May. 2020 was Jeffrey L. Ives's most active year for disposing of shares, totalling 13 transactions. Jeffrey L. Ives's most active month to dispose stocks was the month of July. 2020 saw Jeffrey L. Ives paying a total of $173,562.50 for 34,000 shares, this is the most they've acquired in one year. In 2023 Jeffrey L. Ives cashed out on 83,898 shares for a total of $272,333.52, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Cara Therapeutics, Inc.

Investor
Updated Jun 06, 2024
Form 4
722.54%
345.65K
Jun 06, 2024
393.49K
Grant
Jun 04
Form 4
499.63%
77.32K
Jun 05, 2023
92.80K
Grant
Jun 01
Form 4
-18.87%
-3.60K
$9.05
-$32.58K
Jul 19, 2022
15.48K
Sale
ScheduledJul 15
Form 4
401.00%
28.87K
Jun 06, 2022
36.07K
Grant
Jun 02
Form 4
-53.19%
-8.18K
$16.04
-$131.21K
Nov 16, 2021
7.20K
Sale
Nov 12
Form 4
144.67%
15.48K
$13.05
-$32.89K
Jun 07, 2021
26.18K
Grant
ScheduledJun 03 - Jun 07
Form 4/A
-18.94%
-2.50K
$15.75
-$39.37K
Nov 24, 2020
10.70K
Sale
Nov 19
Form 4
30.49%
2.50K
$15.75
$39.37K
Nov 23, 2020
10.70K
Grant
Nov 19
Form 4
300.00%
18.00K
Jun 08, 2020
24.00K
Grant
Jun 04
Form 4
-14.29%
-1.00K
$12.97
-$6.06K
Jun 03, 2020
6.00K
Sale
ScheduledJun 01
Form 4
-26.32%
-2.50K
$12.97
-$15.15K
May 14, 2020
7.00K
Sale
ScheduledMay 12
Form 4
-20.83%
-2.50K
$12.97
-$15.15K
Apr 21, 2020
9.50K
Sale
ScheduledApr 21
Form 4
-17.24%
-2.50K
$12.97
-$15.15K
Mar 06, 2020
12.00K
Sale
ScheduledMar 04
Form 4
-14.71%
-2.50K
$13.09
-$15.72K
Feb 05, 2020
14.50K
Sale
ScheduledFeb 03
Form 4
-12.82%
-2.50K
$13.04
-$15.47K
Jan 06, 2020
17.00K
Sale
ScheduledJan 02
Form 4
-29.41%
-2.50K
$15.58
-$51.27K
Dec 04, 2019
6.00K
Sale
ScheduledDec 02
Form 4
-22.73%
-2.50K
$13.00
-$38.40K
Nov 05, 2019
8.50K
Sale
ScheduledNov 01
Form 4
-18.52%
-2.50K
$11.77
-$32.22K
Oct 03, 2019
11.00K
Sale
ScheduledOct 01
Form 4
-15.62%
-2.50K
$14.32
-$44.97K
Sep 05, 2019
13.50K
Sale
ScheduledSep 03
Form 4
-13.51%
-2.50K
$14.28
-$44.80K
Aug 05, 2019
16.00K
Sale
ScheduledAug 01
Form 4
-11.90%
-2.50K
$13.54
-$41.07K
Jul 03, 2019
18.50K
Sale
ScheduledJul 01
Form 4
15.00K
Jun 06, 2019
15.00K
Grant
Jun 04
Form 4
18.00K
Jun 08, 2018
18.00K
Grant
Jun 06
Form 4
15.00K
Jun 23, 2017
15.00K
Grant
Jun 21
Form 4
15.00K
Jun 17, 2016
15.00K
Grant
Jun 15
Form 4
13.50K
Jun 10, 2015
13.50K
Grant
Jun 08
Form 4
20.00K
Jul 18, 2014
20.00K
Grant
Jul 16
Form 3
Jul 18, 2014
Showing 28 results

Acumen Pharmaceuticals, Inc.

Investor
Updated Jun 10, 2024
Form 4
25.00K
Jun 10, 2024
25.00K
Grant
Jun 10
Form 4
-100.00%
-41.95K
$3.62
-$240.81K
Aug 18, 2023
Sale
Aug 17
Form 4
25.00K
Jun 07, 2023
25.00K
Grant
Jun 06
Form 4
25.00K
Jun 17, 2022
25.00K
Grant
Jun 15
Form 4
34.00K
Jul 02, 2021
34.00K
Grant
Jun 30
Form 3
Jun 30, 2021
Showing 6 results